GeneDx Hldgs reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of GeneDx Hldgs using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-10-29 | $0.04 | $-0.21 | 119.0 % |
Q2 | 2024-07-30 | $-0.10 | $-0.30 | 66.7 % |
Q1 | 2024-04-29 | $-0.33 | $-0.67 | 50.7 % |
Q4 | 2024-02-20 | $-0.69 | $-0.75 | 8.00 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-10-29 | $76.87M | $64.99M | 18.3 % |
Q2 | 2024-07-30 | $70.51M | $59.24M | 19.0 % |
Q1 | 2024-04-29 | $62.42M | $49.46M | 26.2 % |
Q4 | 2024-02-20 | $57.42M | $55.43M | 3.59 % |
GeneDx Hldgs (WGS) is scheduled to report earnings on April 28, 2025. The last reported earnings were for reported on October 29, 2024 for Q3.
The Actual EPS was $0.04, which beat the estimate of $-0.21.
The Actual Revenue was $76.9M, which beat the estimate of $65M.
Browse earnings estimates, EPS, and revenue on all stocks.